AF
BIVV

Arrow Financial’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Arrow Financial’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-32
Closed -$2K – 347
2017
Q4 		$2K Hold
32
– – ﹤0.01% 322
2017
Q3 		$2K Hold
32
– – ﹤0.01% 327
2017
Q2 		$2K Hold
32
– – ﹤0.01% 331
2017
Q1 		$2K Buy
+32
New +$1.58K ﹤0.01% 335

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Arrow Financial's BIVV Position: Q1 2018 in Review

Arrow Financial sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 32 shares — an estimated $2K sold.

Arrow Financial first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Arrow Financial reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Arrow Financial sold 32 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2K.
  • Arrow Financial first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Arrow Financial's Bioverativ Inc. Common Stock position peaked at $2K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Arrow Financial's 13F filing for Q1 2018, filed 25 Apr 2018.